"健养安-安心股养"签约仪式。 深圳赛陆医疗科技有限公司作为建设银行"健养安-安心股养"首批签约拟上市企业，立足世界科技前沿，以国家战略需求为指导，自主创新为核心动力，全 力推动基因测序和空间组学技术的革新与发展，是国产基因测序仪领军企业，获深创投等知名创投机构投资。建行深圳市分行结合企业持股平台架构及上市 进程，为企业量身定制"股权激励+上市服务+金融授信"综合服务方案，为科创企业提供全链条、场景化的养老金融服务。 在当天的揭牌仪式上，建行深圳市分行邀请深圳市慈善会执行副会长、八卦岭社区书记及银发客户共同为建行深圳市八卦岭支行揭牌。至此，深圳地区已挂 牌2家"健养安"养老金融特色网点，深圳建行养老金融服务体系再升级。 转自：新华财经 5月8日，中国建设银行在福建省福州市举办"健养安"养老金融特色网点扩容升级发布会暨养老金融产品服务推介会，并集中揭牌全国第二批"健养安"养老金 融特色网点。建设银行副行长纪志宏出席活动并致辞。中国建设银行深圳市分行（以下简称建行深圳市分行）资深副经理刘星，深圳赛陆医疗科技有限公司 联合创始人、CTO刘二凯参加"健养安-安心股养"股权激励增值服务现场签约。建行深圳市分行第二批"健 ...

Group 1: Robotics Innovations - The "Tiangong" robot, showcased at the Yizhuang exhibition area, is the world's first "human-machine co-running" half marathon champion, with its sibling "Tiangong 2.0" set to be released, featuring advanced capabilities for complex terrain navigation [1] - The Walker S1 humanoid robot from UBTECH is designed for general tasks, utilizing advanced technologies such as multimodal planning and semantic VSLAM, enhancing its agility and intelligence for industrial applications [1] Group 2: Medical Technology Advancements - Changmu Valley Medical Technology Co., Ltd. introduced the ROPA orthopedic intelligent surgical robot system, which is the first to achieve "integrated diagnosis and treatment" in orthopedic AI surgery, addressing the dependency on imported technologies [2] Group 3: Aerospace and Quantum Computing Breakthroughs - Beijing Xingtu Zhili Technology Co., Ltd. launched the "Netling Satellite Internet Terminal," the first domestically produced satellite communication device for civilian use, which was successfully deployed during the 2025 Myanmar earthquake rescue [2] - The new generation coherent optical quantum computer from Beijing Boson Quantum Technology Co., Ltd. has surpassed the 1000-bit scale, offering exponential computational power compared to classical computers, significantly reducing processing time in drug discovery [3] Group 4: Overall Impact of the Expo - The Beijing International Science and Technology Industry Expo serves as a platform for showcasing technological achievements, facilitating the transformation of scientific results and promoting collaborative industrial development [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 会议召开时间：2025年05月16日(星期五) 下午 13:15-14:45 ● 会议参与方式一：上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/）； 会议参与方式二："麦迪科技投资者关系"小程序，通过微信搜索"麦迪科技投资者关系"或微信扫一扫以 下二维码参与会议 副董事长、总经理翁康先生；独立董事李东先生；副总经理、董事会秘书李孟豪先生；财务总监梅皓先 生。 四、 投资者参加方式 （一）投资者可在2025年05月16日下午13:15-14:45，通过互联网登录上证路演中心 ● 会议召开方式：视频直播和网络互动 ● 投资者可于2025年05月09日(星期五)至05月15日(星期四)16:00前登录上证路演中心网站首页点击"提问 预征集"栏目或通过公司邮箱suzhoumedi001@medicalsystem.cn进行提问。公司将在说明会上对投资者普 遍关注的问 ...

Group 1 - The company, Yaoshi Bang (9885.HK), has initiated a share buyback program, repurchasing 300,000 shares for approximately HKD 2.104 million at an average price of HKD 7.0147 per share, with plans to utilize up to HKD 1 billion for further buybacks by October 31, 2025, indicating positive expectations for its performance and market future [1][2] - The company's financial performance has shown significant improvement, with a reported revenue of HKD 17.904 billion for 2024, representing a year-on-year growth of 5.5%, and a net profit of HKD 157 million, up 20.1%, marking its first annual profit [1] - The company has demonstrated strong cash flow management, with inventory turnover days at only 31 days and a cash cycle of -28.9 days, highlighting its effective inventory and cash management practices [1] Group 2 - The company is characterized as a "cigar butt stock" due to its stable operations and abundant cash flow, which are currently undervalued in the market, attracting attention from public funds [2] - Analysts suggest that the potential for short-term valuation recovery exists, as the stock price may revert to its intrinsic value with improved market sentiment or industry conditions, while quality companies can achieve long-term value enhancement through operational improvements [2] - With ongoing domestic policy support for optimizing grassroots medical resource allocation, companies like Yaoshi Bang, which have a digitalization advantage, are expected to enter a rapid development phase, creating opportunities for medium to long-term investments [2]

Group 1 - The core business of the company is providing Clinical Information System (CIS) software and overall solutions for clinical medical management [2] - The company's main product, DoCare, covers critical areas such as operating rooms, intensive care units, pre-hospital emergency care, and in-hospital emergency services [2] - The company has a user base of over 2,400 medical institutions across 32 provinces, including nearly 1,200 tertiary hospitals [2] Group 2 - As of March 31, 2025, the number of shareholders increased by 11,318 to a total of 48,361, with an average holding value of 352,800 yuan per shareholder [1] - The latest financial report for Q1 2025 shows a revenue of 63.34 million yuan, a year-on-year decrease of 43.13%, while net profit increased by 138.55% to 23.60 million yuan [3] - The company has a current market capitalization of 4.554 billion yuan and a price-to-book ratio of 5.53 [1][4]

Group 1: Tesla Developments - Tesla plans to release an unsupervised version of its Full Self-Driving (FSD) feature within a few months, with testing starting in Austin in June and rapid rollout across the U.S. [4] - The company aims for future manual driving to become as rare as horseback riding, indicating a significant shift in transportation norms [4] Group 2: Robotics and AI Innovations - Tesla is developing a humanoid robot named Optimus, which is expected to assist individuals in various tasks, representing a substantial market opportunity [4] - The AI system Grok has been developed to perform complex analyses accurately, emphasizing the importance of instilling a truth-seeking value in AI for safety [9] Group 3: SpaceX and Multiplanetary Goals - SpaceX focuses on rocket launches and Starlink internet operations, with ambitions to develop technologies that enable human survival on other planets, particularly Mars [6] Group 4: Neuralink's Medical Advancements - Neuralink is working on a brain-machine interface device called "Mind Reading," allowing paralyzed patients to control devices using thoughts, with current users able to communicate via the X platform [6] - A second device, "Blind Vision," aims to restore sight to blind individuals by connecting directly to the visual cortex, with initial surgeries expected within the next year [8] - The company is optimistic about enabling individuals with spinal cord injuries to regain mobility by bridging signals from the brain to damaged areas of the spine [8] Group 5: Legacy and Vision - The company aims to leave a legacy of advancing civilization, enhancing knowledge, and helping humanity understand the universe [11]

Market Overview - US stock index futures are all down, with Dow futures down 0.77%, S&P 500 futures down 0.93%, and Nasdaq futures down 1.21% [1] - European indices also show declines, with Germany's DAX down 0.89%, UK's FTSE 100 down 0.22%, France's CAC40 down 0.52%, and the Euro Stoxx 50 down 0.70% [2] - WTI crude oil increased by 2.15% to $58.36 per barrel, while Brent crude rose by 2.06% to $61.47 per barrel [2] Company News - Goldman Sachs indicates that recent earnings reports from major tech companies in the AI sector have boosted investor confidence, suggesting that recent pullbacks present a buying opportunity [3] - DoorDash reported Q1 revenue growth of 20.7% to $3.03 billion, with adjusted EBITDA of $590 million, exceeding market expectations [4] - Philips lowered its annual profit forecast due to the impact of US tariffs, estimating a net effect of €250 million to €300 million (approximately $283 million to $340 million) [5] - Palantir's Q1 revenue surged 39% to $884 million, leading to an upward revision of its 2025 revenue forecast to approximately $3.9 billion, a 36% year-over-year increase [5] - Ford's Q1 revenue fell 5% to $40.7 billion but exceeded analyst expectations, while the company withdrew its full-year profit guidance [6] - Apple is expected to launch AI features in China with support from Alibaba and Baidu, integrating local compliance mechanisms [7] - WeRide expanded its strategic partnership with Uber to deploy autonomous Robotaxi services in 15 cities over the next five years [8] - The US Department of Justice is pushing for the forced divestiture of Google's online advertising business, citing illegal monopoly practices [9]

Core Viewpoint - The rapid advancement of artificial intelligence technology is leading to an increase in AI-assisted medical scenarios, particularly in ultrasound technology and robotic applications for efficient patient care [1][2]. Group 1: Technology Development - The research team from the Chinese Academy of Sciences has developed intelligent ultrasound technology and ultrasound robots to provide convenient and efficient medical services [1]. - The proposed "robot + AI + handheld ultrasound" technology aims to address the complexity of ultrasound operations, which heavily rely on the expertise of ultrasound doctors [1]. - The team has integrated AI image analysis, operator action analysis, and autonomous decision-making of robots to achieve multi-modal information fusion and decision-making [1]. Group 2: Product Features - The developed lightweight desktop robot for thyroid and carotid artery examinations allows for guided scanning paths and real-time quality monitoring, enabling operators to follow robot prompts for standardized scanning [1]. - An AI diagnostic engine has been created based on extensive ultrasound image data to enhance the sensitivity and specificity of lesion identification [2]. - The ultrasound probe and processing system have been miniaturized to the size of a mobile phone, combined with a cloud-based intelligent analysis system, facilitating a service model that brings equipment to communities while experts operate remotely [2]. Group 3: Implementation and Impact - The technology has been implemented in over 10 grassroots medical institutions, conducting nearly 100,000 carotid ultrasound screenings [3]. - The research team is expanding the technology to include screenings for additional organs such as the breast and liver, aiming to make high-quality medical resources more accessible [3].

Core Insights - The rapid iteration of artificial intelligence technology is increasing the scenarios for AI-assisted healthcare, with a focus on intelligent ultrasound technology and ultrasound robots developed by the Chinese Academy of Sciences' Automation Research Institute [1][2] - The developed technology aims to address the complexity of ultrasound equipment operation, which heavily relies on the expertise of ultrasound doctors, particularly in underdeveloped areas where misdiagnosis can delay treatment [1] - The research team has created a lightweight desktop robot for thyroid and carotid artery examinations, integrating AI image analysis and real-time monitoring to facilitate standardized scanning by operators [1] Group 1 - The intelligent ultrasound technology can be used for precise assessment of organ lesions, serving as an important tool for early screening of cardiovascular diseases and cancers [1] - The team has developed an AI diagnostic engine based on extensive ultrasound image data, enhancing the sensitivity and specificity of lesion identification [2] - The ultrasound probe and processing system have been integrated into a device the size of a mobile phone, enabling a service model that brings equipment to communities while experts analyze data in the cloud [2] Group 2 - The technology has been implemented in over 10 grassroots medical institutions, conducting nearly 100,000 carotid ultrasound screenings [3] - The research team is expanding the technology to include screenings for additional organs such as the breast and liver, aiming to make quality medical resources more accessible [3]

Core Viewpoint - The article discusses the importance of AI ethics, particularly in the medical field, emphasizing the need for "human-machine alignment" to ensure AI technologies align with human values and societal norms [2][3]. Group 1: Human-Machine Alignment - Human-machine alignment is defined as the process of ensuring AI's goals, behaviors, and outputs are consistent with human values and social norms, representing a systematic approach to addressing AI ethical issues [3]. - The concept of human-machine alignment has historical roots, with its principles being validated through practical applications in AI technology [3][6]. Group 2: Importance in Medical AI - In the medical field, human-machine alignment serves three core functions: explainability, trustworthiness, and human harmony [4][5]. - Explainability allows AI to present clear decision-making logic, which helps alleviate concerns from both doctors and patients [4]. - Trust is built when AI recommendations adhere to medical ethics, enabling humans to rely on AI for health-related decisions [5]. - Human harmony ensures that AI applications do not deviate from genuine human needs, incorporating emotional and ethical considerations into algorithm design [5]. Group 3: Ethical Compliance in Medical AI - Medical AI applications face unique challenges, including data sensitivity, irreversible outcomes, and complex responsibility structures [7]. - A collaborative approach across five key areas—technical architecture, data set construction, hospital management, patient awareness, and industry regulation—is essential for ensuring ethical compliance in medical AI [7][9]. Group 4: Data Mechanisms - Establishing a "data flywheel" mechanism is crucial for continuous model optimization, creating a closed-loop system that integrates user feedback into AI development [11]. - A dual mechanism for data access and incentives is necessary to ensure data quality and encourage participation from hospitals and doctors in the alignment process [12]. Group 5: Regulatory Framework - A unified national certification standard for medical AI alignment should be established, with third-party evaluations to ensure compliance and robustness [10]. - Regular assessments by multidisciplinary ethical committees can help maintain alignment and prevent technological biases [10].